Previous close | 2.2500 |
Open | N/A |
Bid | 0.0000 |
Ask | 3.8000 |
Strike | 35.00 |
Expiry date | 2024-10-18 |
Day's range | 2.2500 - 2.2500 |
Contract range | N/A |
Volume | |
Open interest | 5 |
First Quarter 2024 Earnings Summary and Raised Financial Guidance
Total Revenue Increased 25% to $51.3 Million Record First Quarter MACI Revenue of $40.2 Million and Burn Care Revenue Growth of 63% Adjusted EBITDA Growth of 325% Full-Year 2024 Revenue Guidance Raised to $238-$242 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for
Key Insights Vericel's Annual General Meeting to take place on 1st of May Salary of US$790.0k is part of CEO Nick...